EP1080185A4 - Myelin basic protein peptides and uses thereof - Google Patents

Myelin basic protein peptides and uses thereof

Info

Publication number: EP1080185A4
Authority: EP; European Patent Office
Prior art keywords: basic protein; myelin basic; protein peptides; peptides; myelin
Prior art date: 1998-05-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99920379A

Other languages

German (de)

French (fr)

Other versions

EP1080185A2 (en

Inventor

Subhashini Arimilli

Shrikant Deshpande

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Corixa Corp

Original Assignee

Corixa Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-05

Filing date

1999-05-05

Publication date

2005-01-26

1999-05-05 Application filed by Corixa Corp filed Critical Corixa Corp

2001-03-07 Publication of EP1080185A2 publication Critical patent/EP1080185A2/en

2005-01-26 Publication of EP1080185A4 publication Critical patent/EP1080185A4/en

Status Withdrawn legal-status Critical Current

Links

KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 title 1
102000047918 Myelin Basic Human genes 0.000 title 1
101710107068 Myelin basic protein Proteins 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rehabilitation Therapy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP99920379A 1998-05-05 1999-05-05 Myelin basic protein peptides and uses thereof Withdrawn EP1080185A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US7310998A	1998-05-05	1998-05-05
US73109		1998-05-05
PCT/US1999/009930 WO1999057241A2 (en)	1998-05-05	1999-05-05	Myelin basic protein peptides and uses thereof

Publications (2)

Publication Number	Publication Date
EP1080185A2 EP1080185A2 (en)	2001-03-07
EP1080185A4 true EP1080185A4 (en)	2005-01-26

Family

ID=22111789

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99920379A Withdrawn EP1080185A4 (en)	1998-05-05	1999-05-05	Myelin basic protein peptides and uses thereof

Country Status (10)

Country	Link
EP (1)	EP1080185A4 (en)
JP (1)	JP2002513558A (en)
CN (1)	CN1308671A (en)
AU (1)	AU3789099A (en)
CA (1)	CA2330826A1 (en)
HK (1)	HK1039636A1 (en)
NO (1)	NO20005547L (en)
NZ (1)	NZ507901A (en)
WO (1)	WO1999057241A2 (en)
ZA (1)	ZA200006268B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002254753C1 (en) *	2001-05-01	2008-09-18	The Regents Of The University Of California	Fusion molecules and methods for treatment of immune diseases
US7265208B2 (en)	2001-05-01	2007-09-04	The Regents Of The University Of California	Fusion molecules and treatment of IgE-mediated allergic diseases
ITFI20010114A1 (en) *	2001-06-22	2002-12-22	Univ Firenze	GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS
WO2009066175A1 (en) *	2007-11-20	2009-05-28	Eldrug S.A.	Peptide analogues and conjugates thereof
US20180064792A1 (en) *	2015-03-30	2018-03-08	Osaka University	Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disease containing same, and method for treating immune disease
JP7818405B2 (en) *	2019-06-18	2026-02-20	ザスクリプスリサーチインスティテュート	Methods and compositions for treating inflammatory conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996012737A2 (en) *	1994-10-25	1996-05-02	Immulogic Pharmaceutical Corporation	Compositions and treatment for multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5734023A (en) *	1991-11-19	1998-03-31	Anergen Inc.	MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
AU6331696A (en) *	1995-06-07	1996-12-30	Anergen, Inc.	Fused soluble mhc heterodimer:peptide complexes and their uses

1999
- 1999-05-05 CN CN99808248A patent/CN1308671A/en active Pending
- 1999-05-05 JP JP2000547197A patent/JP2002513558A/en active Pending
- 1999-05-05 CA CA002330826A patent/CA2330826A1/en not_active Abandoned
- 1999-05-05 HK HK02101092.3A patent/HK1039636A1/en unknown
- 1999-05-05 EP EP99920379A patent/EP1080185A4/en not_active Withdrawn
- 1999-05-05 AU AU37890/99A patent/AU3789099A/en not_active Abandoned
- 1999-05-05 WO PCT/US1999/009930 patent/WO1999057241A2/en not_active Ceased
- 1999-05-05 NZ NZ507901A patent/NZ507901A/en unknown
2000
- 2000-11-02 ZA ZA200006268A patent/ZA200006268B/en unknown
- 2000-11-03 NO NO20005547A patent/NO20005547L/en not_active Application Discontinuation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996012737A2 (en) *	1994-10-25	1996-05-02	Immulogic Pharmaceutical Corporation	Compositions and treatment for multiple sclerosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9957241A3 *
WUCHERPFENNIG K W ET AL: "STRUCTURAL REQUIREMENTS FOR BINDING OF AN IMMUNODOMINANT MYELIN BASIC PROTEIN PEPTIDE TO DR2 ISOTYPES AND FOR ITS RECOGNITION BY HUMAN T CELL CLONES", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 179, no. 1, January 1994 (1994-01-01), pages 279 - 290, XP000655184, ISSN: 0022-1007 *

Also Published As

Publication number	Publication date
WO1999057241A2 (en)	1999-11-11
HK1039636A1 (en)	2002-05-03
JP2002513558A (en)	2002-05-14
ZA200006268B (en)	2001-08-22
AU3789099A (en)	1999-11-23
NZ507901A (en)	2003-06-30
WO1999057241A9 (en)	2000-02-17
EP1080185A2 (en)	2001-03-07
CN1308671A (en)	2001-08-15
NO20005547L (en)	2001-01-02
CA2330826A1 (en)	1999-11-11
WO1999057241A3 (en)	2000-01-13
NO20005547D0 (en)	2000-11-03

Legal Events

Date	Code	Title	Description
2001-01-19	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-03-07	17P	Request for examination filed	Effective date: 20001130
2001-03-07	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2005-01-26	A4	Supplementary search report drawn up and despatched	Effective date: 20041215
2005-04-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-06-08	18D	Application deemed to be withdrawn	Effective date: 20040602

Publication	Publication Date	Title
PL346346A1 (en)	2002-02-11	Cyclic prosaposin-derived peptides and uses thereof
HUP0102535A3 (en)	2005-12-28	Cd19xcd3 specific polypeptides and uses thereof
GB9806806D0 (en)	1998-05-27	Peptides and uses thereof
AU5340399A (en)	2000-03-06	Proteases and associated proteins
GB9719879D0 (en)	1997-11-19	Protein
AP2001002189A0 (en)	2001-06-30	Genes and proteins and their uses
IL131707A0 (en)	2001-03-19	Acetylcholinesterase-derived peptides and uses thereof
EP1140976A4 (en)	2003-05-21	Secreted proteins and uses thereof
GB9718110D0 (en)	1997-10-29	Peptides
IL128570A0 (en)	2000-01-31	Protein kinases and uses thereof
GB9918155D0 (en)	1999-10-06	Proteins and peptides
EP1080185A4 (en)	2005-01-26	Myelin basic protein peptides and uses thereof
GB9700154D0 (en)	1997-02-26	Peptides
GB9714276D0 (en)	1997-09-10	Peptides and related compounds
IL137493A0 (en)	2001-07-24	Svph3-13 and spvh3-17 dna and polypeptides
GB9720784D0 (en)	1997-12-03	Protein
GB9828704D0 (en)	1999-02-17	Proteins
EP1142999A4 (en)	2002-08-28	Novel protein and dna thereof
GB9824357D0 (en)	1998-12-30	Protein and DNA coding therefor
EP1111047A4 (en)	2002-10-02	Novel protein and dna thereof
GB9809566D0 (en)	1998-07-01	Protein
GB9816336D0 (en)	1998-09-23	Proteins
EP1141269A4 (en)	2003-03-26	Secreted proteins and uses thereof
NZ513920A (en)	2001-09-28	Novel proteins and uses thereof
IL120392A0 (en)	1998-02-22	Novel PKA-binding proteins and uses thereof